EUVIMEDEUVIMED entdecken
Crossref

IL-10 and IL-18: Key players in liver damage associated with hepatitis A virus infection

Zahraa A Hussein, Saif D Al-Ahmar

Human Antibodies · 2024

DOI: 10.3233/hab-240039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Antibodies, 2024. Verfasst von Zahraa A Hussein und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hepatitis A, Hepatitis A virus, Interleukin-10, Interleukin-18. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatitis A virus infection is a health threat with multiple transmission patterns across areas, It is evaluated using immune response markers IL-10 and IL-18, along with molecular and biochemical diagnostic methods for accurate diagnosis. OBJECTIVE: The association between liver damage and interleukin-10 and interleukin-18 levels in people with hepatitis A virus infection as indications of the risk of acute liver failure. METHODS: 110 samples were collected from Iraqi individuals from both sexes and different age groups [Formula: see text] 1 to [Formula: see text] 25, including 60 patients and 50 healthy people. All samples were collected from a hospital in Diwaniyah city, and the infection was confirmed by antiHAV IgM titers and One-Step RT-PCR. ELISA was used to determine the levels of IL-10 and IL-18, while Biochemical tests measured for alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total serum Bilirubin (TSB) in serum. RESULTS: In this study, IL-10 levels were higher in HAV patients (0.12 [Formula: see text] 0.06 ng/L) compared to controls (0.11 [Formula: see text] 0.04 ng/L), but the difference was not significant ([Formula: see text] 0.17). Conversely, IL-18 levels were significantly elevated in patients (1.41 [Formula: see text] 0.71) versus controls (0.58 [Formula: see text] 0.35) ([Formula: see text] 0.00). Biochemical tests showed significantly elevated levels in HAV patients: ALT (170.18 [Formula: see text] 117.67 vs. 21.25 [Formula: see text] 7.41), AST (183.05 [Formula: see text] 128.13 vs. 26.00 [Formula: see text] 7.69), ALP (607.68 [Formula: see text] 214.93 vs. 202.02 [Formula: see text] 121.35), and TSB (2.77 [Formula: see text] 2.5 vs. 0.55 [Formula: see text] 0.14) (all [Formula: see text] 0.001). These findings underscore the potential of IL-10 and IL-18 as biomarkers for HAV severity and highlight their role in liver injury. CONCLUSION: Our study highlights the important roles of IL-10 and IL-18 in acute hepatitis A and reveals their impact on the immune response and liver damage. Elevated levels of IL-10, IL-18 and Biochemical tests are associated with disease severity, suggesting their potential as biomarkers and therapeutic targets to improve the management of HAV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis AHepatitis A virusInterleukin-10Interleukin-18LiverAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleYoung AdultAlanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesBilirubinBiomarkersCase-Control StudiesIraq

Stichwörter der Autor:innen

ALFHAVIL-10IL-18one step-PCR

Substanzen

Alanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesBilirubinBiomarkersIL10 protein, humanIL18 protein, humanInterleukin-10Interleukin-18

Zitieren

APA

Hussein, Z. A., & Al-Ahmar, S. D. (2024). IL-10 and IL-18: Key players in liver damage associated with hepatitis A virus infection. Human Antibodies. https://doi.org/10.3233/hab-240039

Vancouver

Hussein ZA, Al-Ahmar SD. IL-10 and IL-18: Key players in liver damage associated with hepatitis A virus infection. Human Antibodies. 2024. doi:10.3233/hab-240039

BibTeX
@article{Hussein2024,
  author = {Hussein, Zahraa A and Al-Ahmar, Saif D},
  title = {IL-10 and IL-18: Key players in liver damage associated with hepatitis A virus infection},
  journal = {Human Antibodies},
  year = {2024},
  doi = {10.3233/hab-240039}
}
Kostenlos starten →